Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Consulting agrmnt
CC transcript
Employment agrmnt
Director departure
Appointed COO
Appointed director
Asset disposition
|
|
Aeon Global Health Corp. (AGHC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/05/2019 |
8-K
| Other Events |
| 10/01/2019 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits|
Docs:
|
"DEBT CONVERSION AGREEMENT This Debt Conversion Agreement is entered into effective as of ________, 2019 by and between __________ and Aeon Global Health Corp., a Delaware corporation , with reference to the following facts: WHEREAS, Debt Holder holds promissory notes and other debt totaling $_________, of which the Company and the Debt Holder desire to convert $_________ into common shares of the Company. NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Debt Holder and the Company agree as follows: 1. Conversion to Common Stock. Effective as of _________, 2019, $_________ of the Debt shall be converted into common shares at a price per share of $0.105 for an aggregate number of shares of __________. Upon execution of this Agr..." |
|
| 01/24/2019 |
8-K
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review |
| 01/23/2019 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 12/21/2018 |
8-K
| Other Events |
| 12/11/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/01/2018 |
8-K
| Quarterly results |
| 09/13/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/24/2018 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 07/02/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/20/2018 |
8-K
| Other Events |
| 04/03/2018 |
8-K
| Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce... |
| 03/28/2018 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 02/01/2018 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits |
| 01/10/2018 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits|
Docs:
|
"Aeon Global Health Names Armando Moncada, MD, FCAP as Chief Medical Officer of its Anatomic Pathology Business Company Also Announces Agreement to Acquire Certain IP Assets of PCG Molecular, LLC For Immediate Release: Gainesville, GA, January 10, 2018: Aeon Global Health , a growth-oriented provider of personalized, clinically actionable medical informatics and telemedicine, announced today that Armando Moncada, MD, FCAP, has been appointed to the position of Chief Medical Officer of its Anatomic Pathology business line. Dr. Moncada has more than 20 years’ experience in the pathology field, the last ten of which he served as Chief Medical Officer of PCG Molecular. He has expertise in the fields of gynecologic, breast, and head and neck pathology and cytopathology as well as in molecular pa..." |
|
| 12/12/2017 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 10/02/2017 |
8-K
| Quarterly results |
| 09/14/2017 |
8-K
| Quarterly results |
| 09/13/2017 |
8-K
| Quarterly results |
| 06/07/2017 |
8-K
| Form 8-K - Current report |
| 04/24/2017 |
8-K
| Form 8-K - Current report |
| 03/24/2017 |
8-K
| Form 8-K - Current report |
| 03/03/2017 |
8-K
| Form 8-K - Current report |
| 02/22/2017 |
8-K
| Form 8-K - Current report |
| 02/06/2017 |
8-K
| Form 8-K - Current report |
| 01/18/2017 |
8-K
| Form 8-K - Current report |
| 12/21/2016 |
8-K
| Form 8-K - Current report |
| 12/13/2016 |
8-K
| Form 8-K - Current report |
| 08/12/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/13/2016 |
8-K
| Form 8-K - Current report |
| 06/06/2016 |
8-K
| Form 8-K - Current report |
| 04/29/2016 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Authentidate Announces AEON's audited results for the year ended December 31, 2015 2015 Revenue of $34.85 Million Net Income of $13.75 Million EBITDA of $16.36 Million BERKELEY HEIGHTS, N.J., April 25, 2016 — Authentidate Holding Corp. , one of the fastest growing clinical labs in North America through its wholly owned subsidiary, Aeon Clinical Laboratories , and a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced AEON's audited results for the year ended December 31, 2015. On January 27, 2016, Authentidate closed a merger transaction whereby privately-held AEON merged with a wholly-owned subsidiary of Authentidate, creating a combined company focused on delivering innovative solutions that ..." |
|
| 04/14/2016 |
8-K
| Form 8-K - Current report |
| 03/15/2016 |
8-K
| Form 8-K - Current report |
|
|
|